NEW YORK (GenomeWeb) – Epic Sciences said today that it has completed a $40 million Series D financing.

Hermed Capital led the round, which also included Altos Capital Partners, Domain Associates, Genomic Health, Pagoda Investment, Reach Tone Limited, RMI Partners, Sabby Capital, and VI Ventures.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.